港股异动 | 科济药业-B(02171)现涨超7% 公司拟在2025年ASH年会发布CT0596临床数据

Group 1 - The core point of the article is that Kintor Pharmaceutical (科济药业-B) has seen a stock price increase of over 7%, currently trading at 19.98 HKD with a transaction volume of 10.51 million HKD [1] - Kintor Pharmaceutical announced that it will present clinical data for CT0596 at the 67th American Society of Hematology (ASH) annual meeting [1] - On September 20, the National Healthcare Security Administration announced the completion of expert review for the first version of the commercial insurance innovative drug catalog, with Kintor's CAR-T drug, Sai Ke Ze, among five CAR-T drugs that passed the review, potentially entering the basic medical insurance catalog and commercial insurance innovative drug catalog this year [1]